BEAT Fundamental Analysis - HEARTBEAM INC

Fundamental Rating

Overall BEAT gets a fundamental rating of 2 out of 10. We evaluated BEAT against 191 industry peers in the Health Care Equipment & Supplies industry. While BEAT seems to be doing ok healthwise, there are quite some concerns on its profitability. BEAT is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

BEAT had negative earnings in the past year.

BEAT had a negative operating cash flow in the past year.

BEAT had negative earnings in each of the past 5 years.

In the past 5 years BEAT always reported negative operating cash flow.

1.2 Ratios

BEAT has a worse Return On Assets (-340.14%) than 97.91% of its industry peers.

BEAT has a worse Return On Equity (-486.47%) than 84.29% of its industry peers.

		Industry Rank	Sector Rank
ROA	-340.14%
ROE	-486.47%
ROIC	N/A

ROA(3y)-333.3%

ROA(5y)-634.31%

ROE(3y)-604.84%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

BEAT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The number of shares outstanding for BEAT has been increased compared to 1 year ago.

The number of shares outstanding for BEAT has been increased compared to 5 years ago.

BEAT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of -6.45, we must say that BEAT is in the distress zone and has some risk of bankruptcy.

The Altman-Z score of BEAT (-6.45) is worse than 72.77% of its industry peers.

There is no outstanding debt for BEAT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	-6.45

ROIC/WACCN/A

WACCN/A

2.3 Liquidity

BEAT has a Current Ratio of 2.98. This indicates that BEAT is financially healthy and has no problem in meeting its short term obligations.

BEAT has a Current ratio (2.98) which is in line with its industry peers.

A Quick Ratio of 2.98 indicates that BEAT has no problem at all paying its short term obligations.

BEAT's Quick ratio of 2.98 is fine compared to the rest of the industry. BEAT outperforms 67.54% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.98
Quick Ratio	2.98

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

BEAT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -9.37%.

EPS 1Y (TTM)-9.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.05%

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 22.37% on average over the next years. This is a very strong growth

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y23.85%

EPS Next 2Y7.13%

EPS Next 3Y22.37%

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BEAT. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BEAT. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

BEAT's earnings are expected to grow with 22.37% in the coming years. This may justify a more expensive valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y7.13%

EPS Next 3Y22.37%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

BEAT does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

HEARTBEAM INC

NASDAQ:BEAT (10/17/2025, 4:30:01 PM)

1.71

-0.02 (-1.16%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)08-13 2025-08-13/amc

Earnings (Next)11-06 2025-11-06/amc

Inst Owners10.48%

Inst Owner Change0%

Ins Owners11.51%

Ins Owner Change0%

Market Cap58.67M

Analysts80

Price Target4.59 (168.42%)

Short Float %0.79%

Short Ratio1.98

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-4.78%

Min EPS beat(2)-17.65%

Max EPS beat(2)8.09%

EPS beat(4)2

Avg EPS beat(4)-2.22%

Min EPS beat(4)-17.65%

Max EPS beat(4)8.09%

EPS beat(8)3

Avg EPS beat(8)-5.24%

EPS beat(12)4

Avg EPS beat(12)-10.11%

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)-43.75%

EPS NQ rev (1m)0%

EPS NQ rev (3m)8%

EPS NY rev (1m)4.39%

EPS NY rev (3m)4.39%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)-50%

Revenue NY rev (1m)0%

Revenue NY rev (3m)-49.18%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	N/A
P/FCF	N/A
P/OCF	N/A
P/B	14.03
P/tB	14.03
EV/EBITDA	N/A

EPS(TTM)-0.7

EYN/A

EPS(NY)-0.62

Fwd EYN/A

FCF(TTM)-0.45

FCFYN/A

OCF(TTM)-0.45

OCFYN/A

SpS0

BVpS0.12

TBVpS0.12

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-340.14%
ROE	-486.47%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-333.3%

ROA(5y)-634.31%

ROE(3y)-604.84%

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	2928.57%
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.98
Quick Ratio	2.98
Altman-Z	-6.45

F-Score4

WACCN/A

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-9.37%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%21.05%

EPS Next Y23.85%

EPS Next 2Y7.13%

EPS Next 3Y22.37%

EPS Next 5YN/A

Revenue 1Y (TTM)N/A

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-15.99%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-21.57%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-19.97%

OCF growth 3YN/A

OCF growth 5YN/A

HEARTBEAM INC (BEAT) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens